AbinoNutra

AbinoNutra is a biotechnology company focused on the development of innovative nutritional and therapeutic solutions for metabolic and age-related diseases. The company specializes in the discovery and development of potent sirtuin activators, particularly targeting SIRT1, to address conditions such as sarcopenia and metabolic syndrome. Their lead program, Abino-1, is a proprietary small molecule designed to enhance muscle health and metabolic function. By integrating advanced molecular biology with nutritional science, AbinoNutra aims to provide evidence-based interventions that promote healthy aging and longevity. The company's research is rooted in the science of NAD+ metabolism and cellular energy regulation. AbinoNutra operates at the intersection of biotechnology and nutraceuticals, seeking to validate its compounds through rigorous clinical study.